Key Legislative Changes in the Pharmaceutical and Healthcare Sectors in 2025

Experts at REVERA Law Group have prepared a practical overview of the key changes that shaped the pharmaceutical industry in 2025 in Belarus, the EAEU member states, as well as Georgia and Kazakhstan.

The material is business-focused and practical in nature: it provides a structured analysis of the main regulatory developments, current requirements, and emerging trends that market participants are already encountering. Particular attention is given to the harmonisation of rules within the EAEU, changes to the procedures for the registration of medicinal products and medical devices, as well as the development of approaches in the areas of GLP, GCP, and the use of real-world clinical data.

The overview is based on the expertise of specialists with substantial experience in supporting projects across different jurisdictions, which makes it possible to assess these developments comprehensively and to evaluate their impact on companies’ business processes.

The document will help pharmaceutical and medical companies adapt to new requirements in a timely manner, develop appropriate regulatory strategies, and minimise legal risks.

Download the full overview to learn more about the key trends and the practical aspects of these changes.